ENTRY       D11794                      Drug
NAME        Bempedoic acid and ezetimibe;
            Nexlizet (TN)
PRODUCT     NEXLIZET (Esperion Therapeutics)
REMARK      ATC code: C10BA10
            Product: D11794<US>
EFFICACY    Antidyslipidemia
  DISEASE   Heterozygous familial hypercholesterolemia [DS:H00155]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C10 LIPID MODIFYING AGENTS
               C10B LIPID MODIFYING AGENTS, COMBINATIONS
                C10BA Combinations of various lipid modifying agents
                 C10BA10 Bempedoic acid and ezetimibe
                  D11794  Bempedoic acid and ezetimibe &lt;US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Dyslipidemics, Other
               Ezetimibe/ Bempedoic Acid
                D11794  Bempedoic acid and ezetimibe
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11794
DBLINKS     PubChem: 405226660
///
